Deerfield Mgmt, L.P. 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-17 11:01 am Purchase | 2021-03-15 | 13G | Xeris Biopharma Holdings, Inc. XERS | Deerfield Mgmt, L.P. | 12,435,751 9.880% | 6,553,398 (+111.41%) | Filing |
| 2021-02-12 12:31 pm Purchase | 2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Deerfield Mgmt, L.P. | 5,882,353 4.985% | 3,299,062 (+127.71%) | Filing |